Posted by Michael Wonder on 01 Jun 2023
SK bioscience receives marketing authorisation of COVID-19 Vaccine from UK MHRA
30 May 2023 - SKYCovion is the world's first-ever vaccine developed utilising the RoseTTAFold, a software tool that uses deep learning.
SK bioscience has announced today the UK's MHRA has granted marketing authorisation for SK bioscience's COVID-19 vaccine SKYCovion as a primary series for strong immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.
